The purpose of this study is to determine if the administration of GSK958108 can delay
ejaculation in patients with primary premature ejaculation as measured by the ejaculatory
latency time (ELT) using the masturbation model and sexual visual stimulation, and to
evaluate the safety and tolerability of GSK958108 in healthy men with PE